The French EsoGastricTumours Data Base

Recruiting

• Conditions: Esophageal Disease

• Registration Number: NCT02526095
• Lead Sponsor: University Hospital, Lille

Brief Summary

This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2015-08-13
• Study First Submitted QC: 2015-08-14
• Study First Posted: 2015-08-18
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-10
• Last Update Posted: 2020-09-11
• Primary Completion: 2027-05
• Study Completion: 2027-05

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

Patient with

• esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
• Naive treatment for this cancer,
• Naive treatment for this cancer , failing that received neoadjuvant treatment ,
• Male or female ≥ 18 years.
• social protection scheme .
• sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.

Exclusion Criteria

Male or female aged ( e) under 18 years.

• Private person of liberty or under supervision (including guardianship ) .
• People who do not speak French.
• Major Nobody unable to consent .
• Patient FREGAT already included in the base.
• Patient Refusal .

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DIsease free survival	5 year disease free survival

Secondary Outcome Measures

Name	Time	Method
overall survival	5 year overall survival
recurrence rate	5 year recurrence rate
Total number of patients with complications	from the time between inclusion and occurrence of the event, for the duration of 3 years
Total number of complications	from the time between inclusion and occurrence of the event, for the duration of 3 years
Death	from the time between inclusion and occurrence of the event, for the duration of 3 years

Trial Locations

Locations (31)

Chu Amiens Picardie; 🇫🇷 Amiens, France

Chru Besancon; 🇫🇷 Besançon, France

Chu de Grenoble Alpes; 🇫🇷 Grenoble, France

Aphm Hopital Nord; 🇫🇷 Marseille, France

Hu Paris Site Avicenne Aphp; 🇫🇷 Bobigny, France

Hu Paris Nord Site Louis Mourier Aphp; 🇫🇷 Colombes, France

Hu Paris Centre Site Cochin Aphp; 🇫🇷 Paris, France

Hu Paris Sud Site Kremlin Bicetre Aphp; 🇫🇷 Paris, France

Chru Rennes Site Pontchaillou; 🇫🇷 Rennes, France

Institut de Cancerologie de Lorraine; 🇫🇷 Vandœuvre-lès-Nancy, France

Crlcc Francois Baclesse; 🇫🇷 Caen, France

Hopital Estaing - Chu63 - Clermont Ferrand; 🇫🇷 Clermont-Ferrand, France

Hopital Le Bocage Chru Dijon; 🇫🇷 Dijon, France

Clcc Oscar Lambret Lille; 🇫🇷 Lille, France

Hopital St Eloi Chu Montpellier; 🇫🇷 Montpellier, France

Icm - Montpellier; 🇫🇷 Montpellier, France

Chu de Nantes :Site Hôtel-Dieu- Hme; 🇫🇷 Nantes, France

Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse); 🇫🇷 Lyon, France

Hu Est Parisien Site St Antoine Aphp; 🇫🇷 Paris, France

Hopital Haut-Leveque - Chu - Pessac; 🇫🇷 Pessac, France

Hu Saint Louis Site Saint Louis Aphp; 🇫🇷 Paris, France

Hopital Robert Debre Chu Reims; 🇫🇷 Reims, France

Hopital Charles Nicolle Chu Rouen; 🇫🇷 Rouen, France

Hus/Hop Hautepierre; 🇫🇷 Strasbourg, France

Hopital Purpan Chu; 🇫🇷 Toulouse, France

Chu de Tours; 🇫🇷 Tours, France

Institut Gustave Roussy; 🇫🇷 Villejuif, France

Chu de Caen Normandie; 🇫🇷 Caen, France

Hop Claude Huriez Chu Lille; 🇫🇷 Lille, France

C H U Dupuytren Limoges; 🇫🇷 Limoges, France

Chu Nimes; 🇫🇷 Nîmes, France